To measure antigen-specific reactivity of recovered TCR sequences, TCRs were expressed and screened in Jurkat-NFAT-GFP cells as described previously (34 (link)). Paired TCR alpha and beta chains of interest were cloned into a retroviral pMSGV construct as previously described (17 (link)). PBMCs for retroviral transduction were processed and cultured according to our rececent publication(19 (link), 34 (link)). To assess function of the transduced TCRs in human PBMCs, TCR expressing cells were mixed with K562-A2 cells at a ratio of 1:2 (Effector:Target) in the RPMI media and supplemented with 1 μg/ml of anti-CD28/CD49d antibodies (BD Biosciences, 347690) and 1 μg/ml of cognate peptides. For PBMCs, supernatants were collected after 48 hours and analyzed by ELISA (BD Biosciences) to estimate IFN-γ concentration. PBMCs transduced by the vector without a TCR was used as a negative control.